Right carotid Doppler signal to optimize cardiac resynchronisation therapy implant procedure - 05/01/18
, C. Alarcon, G. Viart, A. Savoure, B. Godin, O. Raitiere, H. Eltchaninoff, F. AnselmeBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 2 |
| Iconographies | 1 |
| Vidéos | 0 |
| Autres | 0 |
Résumé |
Background |
Left-ventricular pre-ejection time (LVPET) varies according to cardiac homodynamic performance and is a predictive factor of clinical response to cardiac resynchronisation therapy (CRT) when >140ms. LVPET could then play a role in optimizing CRT implantation. However, its measurement requires the use of echocardiography in apical view, which is hardly compatible with device implantation environment.
Aim |
The objective of this study was to determine the relationship between LVPET measured conventionally from an apical view and time from beginning of QRS to beginning of Doppler signal flow (QWT) recorded at the right carotid.
Methods |
LVPET was measured using M5S probe and pulsed Doppler on aortic flow in apical view using echocardiography. QWT was measured using a Pedoff probe at the right carotid. These measurements were performed during spontaneous rhythm in all patients whenever possible and during left ventricular pacing, right ventricular pacing, and bi-ventricular pacing in CRT patients.
Results |
LVPET and QWT were measured in 53 patients among whom 11 had a CRT device. A linear relationship between LVPET and QWT was observed (R Pearson coefficient=0.926, P<0.001) (Fig. 1). The intra-observatory and inter-observatory variabilities of QWT were 2.3% and 5.7% respectively. According to pacing setting in CRT patients, average variation of LVPET-Ped was equal to 23.3±24.5%.
Conclusion |
Measurements of QWT from right carotid Doppler signal is an easy, reliable and reproducible method that can be used as a surrogate of LVPET. This could allow optimization of pacing sites location during CRT implant procedure.
Le texte complet de cet article est disponible en PDF.Plan
Vol 10 - N° 1
P. 95-96 - janvier 2018 Retour au numéro
Article précédent
- Remote monitoring and inappropriate therapies in ICD patients: The THORN registry
- J. Deharo, S. Boveda, P. Defaye, A. Rosier, N. Sadoul, A. Lazarus, P. Bordachar, D. Klug, P. Ritter, M. Belhameche, D. Babuty, J. Mansourati
- Low cardiac fibrosis biomarkers levels predict cardiac resynchronization therapy response
- G. Massoullié, V. Sapin, S. Ploux, F. Zannad, A. Mulliez, F. Jean, P.Y. Marie, C. Merlin, B. Pereira, M. Andronnache, P. Motreff, C. Vorilhon, G. Clerfond, P. Rossignol, P. Bordachar, R. Eschalier
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?